Melphalan and Other Anticancer Modalities Up-Regulate B7-1 Gene Expression in Tumor Cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (56)
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
1995 • 1,695 citations
Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
1992 • 1,290 citations
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 • 1,154 citations
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
1994 • 681 citations
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.
1995 • 595 citations
B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
1995 • 577 citations
Ionizing radiation induces expression and binding activity of the nuclear factor kappa B.
1991 • 410 citations
Induction of acute phase gene expression by brain irradiation
1995 • 338 citations
Costimulation of T cells for tumor immunity
1993 • 324 citations
Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.
1990 • 300 citations
Expression and functional significance of an additional ligand for CTLA-4.
1993 • 262 citations
Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide.
1986 • 255 citations
Costimulation through B7-2 (CD86) Is Required for the Induction of a Lung Mucosal T Helper Cell 2 (TH2) Immune Response and Altered Airway Responsiveness
1997 • 251 citations
Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland.
1993 • 208 citations
Manipulation of costimulatory signals to enhance antitumor T-cell responses
1995 • 177 citations
A Critical Role for B7/CD28 Costimulation in Experimental Autoimmune Encephalomyelitis: A Comparative Study Using Costimulatory Molecule-Deficient Mice and Monoclonal Antibody Blockade
2000 • 160 citations
Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B.
1993 • 150 citations
Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
1989 • 149 citations
Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes.
1991 • 148 citations
Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?
1996 • 147 citations
A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB
1998 • 132 citations
E-Selectin Gene Induction by Ionizing Radiation Is Independent of Cytokine Induction
1995 • 128 citations
Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.
1996 • 128 citations
B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.
1996 • 123 citations
Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.
1981 • 100 citations
A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB.
1996 • 83 citations
Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases.
1991 • 76 citations
Expression of cytokine mRNA in human melanoma tissues
1995 • 73 citations
Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma.
1990 • 71 citations
Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth
1983 • 60 citations
Low-dose melphalan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumor
1994 • 55 citations
Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma.
1986 • 54 citations
B7-2 Expressed on EL4 Lymphoma Suppresses Antitumor Immunity by an Interleukin 4–dependent Mechanism
1999 • 52 citations
Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
1985 • 46 citations
Transforming growth factor-?-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy
1994 • 37 citations
Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor.
1989 • 36 citations
Importance of tumor-specific cytotoxic CD8+ T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy.
1990 • 33 citations
Enhancement of B7‐1 (CD80) expression on B‐lymphoma cells by irradiation
1999 • 32 citations
Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8+ T cell-dependent mechanism.
1999 • 28 citations
Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory molecule
1996 • 28 citations
Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment.
1997 • 28 citations
Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor β by treatment with bleomycin
1995 • 27 citations
Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
1989 • 27 citations
Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models
1989 • 25 citations
Host B7-1 and B7-2 Costimulatory Molecules Contribute to the Eradication of B7-1-Transfected P815 Tumor Cells Via a CD8+ T Cell-Dependent Mechanism
1999 • 25 citations
Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon γ in the therapeutic outcome
1995 • 22 citations
Importance of TNF production for the curative effectiveness of low dose melphalan therapy for mice bearing a large MOPC-315 tumor.
1995 • 22 citations
Importance of the B7-2 Molecule for Low Dose Melphalan-Induced Acquisition of Tumor-Eradicating Immunity by Mice Bearing a Large MOPC-315 Tumor
1998 • 22 citations
Regulation of NF-κB through the Nuclear Processing of p105 (NF-κB1) in Epstein-Barr Virus-immortalized B Cell Lines
1995 • 19 citations
Importance of B7-1-Expressing Host Antigen-Presenting Cells for the Eradication of B7-2 Transfected P815 Tumor Cells
1998 • 13 citations
Isolation and promoter mapping of the gene encoding murine co-stimulatory factor B7-1
1996 • 12 citations
Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor
1985 • 11 citations
Potentiation of Antitumor CTL Response by GM-CSF Involves a B7-Dependent Mechanism
1997 • 10 citations
Cloning and partial characterization of the mouse B7-1 promoter
1996 • 3 citations
A Novel Stimulus, Oncogene, Induces Expression of CD80 (B7-1) Gene
1999 • 3 citations
Cloning and partial characterization of the mouseB7-1 promoter
1996 • 3 citations
Cited By (0)
No citing papers found in database